L. Saltz, “Octreotide as an antineoplastic Agent in the Treatment of Functional and Non-Functional Neuroendocrine Tumours,” Cancer, Vol. 72, No. 1, 1993, pp. 244-248. doi:10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q

has been cited by the following article:

• TITLE: A Case of DIPNECH and Review of the Current Literature

  AUTHORS: Patrick D. Mitchell, Marcus P. Kennedy, Michael T. Henry

  KEYWORDS: Neuroendocrine; Carcinoid; DIPNECH

  JOURNAL NAME: Open Journal of Respiratory Diseases, Vol.3 No.2, May 28, 2013

  ABSTRACT: Diffuse Idiopathic Neuroendocrine Cell Hyperplasia (DIPNECH) is a rare pulmonary disease. It was first described by Aguayo et al. in 1992, and recognised by the World Health Organisation in 2004 as a precursor lesion to the development of pulmonary carcinoid tumour. DIPNECH has been described in several isolated case reports and series. This article describes a case of DIPNECH and summaries the recent literature in an attempt to raise awareness of this disease and management options.